The patent cliff is coming — What it means for pharma as a sector
A wave of the world’s best-selling drugs is about to lose patent protection. When that happens, cheaper copies (generics and biosimilars) flood in, prices crash, and someone has to manufacture all those cheaper copies. That “someone” is very often an Indian company. This is called a patent cliff. It has happened before, but the one…
